Biogen has announced a new multiyear research study on cognitive decline that will be conducted using the Apple Watch and iPhone.
The observational study is being conducted in collaboration with Apple, according to the announcement, and is set to kick off later this year. The project's primary goal is to establish digital biomarkers for monitoring long-term cognitive performance and to spot early...
Nawah Scientific begins 2021 with $1 million (€0.82M) in additional funds. The Cairo-based health tech startup has secured a second pre-series A fundraise comprising both equity and debt, it announced in a press statement late on 7 Jan.
Funded primarily by Egypt Ventures, the round also saw contributions from the Alexandria Fund, Cairo Angels, Alex Angels, undisclosed angels from Hult...
Bold Health, a London-based company developing digital therapeutics for gastrointestinal conditions, is backing a new University of Pennsylvania-led study that will directly compare the company's cognitive behavior therapy (CBT) app for irritable bowel syndrome (IBS) to Headspace's consumer mindfulness and meditation app.
According to a clinicaltrials.gov listing spotted by Exits & Outcomes,...
Novartis is teaming up with smartpatient to launch a new app feature on the MyTherapy app for patients with wet macular degeneration (AMD) that is focused on educating patients and caregivers about treatment and management.
Called "See What’s Next," the section was specifically designed to help provide patients and their families with resources about navigating life with the disease and giving...
The femtech world is beginning to venture out of the boundaries of reproductive health and into other areas of women’s health, according to panelists at Bayer G4A summit yesterday.
Over the summer, Rock Health report that about 65% of all femtech funding has gone into fertility, pregnancy or motherhood. Today innovators are looking beyond the reproductive umbrella, at how technology and research...
Pharma giant Bayer is kicking off new digital collaboration efforts in the fields of cardiometabolic and renal disease, oncology and women’s health via a new initiative, dubbed the G4A Digital Health Partnership Program.
The program is split into two tracks, one for early-stage companies and another for more experienced companies. It tapped Caria, an AI and data company that matches people...
Home-delivery pharmacy AllianceRx Walgreens Prime is jumping into the oncology space with its new clinical assessment feature that lets cancer patients digitally manage their self-administered therapies.
Specifically, the new feature lets patients with oncology conditions refill their prescriptions online as opposed to over the phone. The way it works is patients can log in to their account and...
Life science technology and clinical trial data company Medidata announced today that it has acquired sensor maker MC10's digital biomarker business. The terms of the deal were not disclosed.
WHAT'S THE IMPACT
Medidata (a subsidiary of Dassault Systèmes) said the purchase will allow it to add biometric data and new analytics capabilities to its Patient Cloud platform, particularly to the benefit...
A new platform aimed at streamlining clinical trials in order to lower costs – and increase the efficiency and success rate of a drug or the development of a medical device – has been unveiled by Ben-Gurion University of the Negev (BGU).
The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors including...
Back in April, Borderlands 3 – a big budget, role-playing first-person shooter videogame that sold over 8 million copies within six months of its release – received a free update that introduced a new mini-game to its players.
Taking the form of a retro-style arcade cabinet in the home base's medical bay, "Borderlands Science" has players shifting colored blocks between rows and columns to solve...
.jpg?itok=MZ_RxCEv "The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors such as patient population recruitment and dropout rate.")
